ITRM News and Press, Iterum Therapeutics plc From 08/05/25

2025-08-05 16:59:18 ET More on Iterum Therapeutics Iterum Therapeutics plc (ITRM) Q2 2025 Earnings Call Transcript Iterum Therapeutics plc (ITRM) Q1 2025 Earnings Call Transcript Iterum Therapeutics Non-GAAP EPS of -$0.13 Iterum targets ORLYNVAH US launch by ...

2025-08-05 16:58:45 ET Iterum Therapeutics plc (ITRM) Q2 2025 Earnings Conference Call August 05, 2025 08:30 AM ET Company Participants Corey N. Fishman - President, CEO & Director Judith M. Matthews - Chief Financial Officer Kevin Dalton - Corporate Particip...

2025-08-05 07:16:20 ET More on Iterum Therapeutics Iterum Therapeutics plc (ITRM) Q1 2025 Earnings Call Transcript Iterum targets ORLYNVAH US launch by Q4 2025 while extending cash runway into 2026 Iterum Therapeutics Non-GAAP EPS of -$0.10 Seeking Alpha ...

SOPHiA GENETICS SA (SOPH) is expected to report for Q2 2025 Investors Title Company (ITIC) is expected to report for Q2 2025 Safehold Inc. (SAFE) is expected to report $0.39 for Q2 2025 First Guaranty Bancshares Inc. (FGBI) is expected to report $-0.2 for Q2 2025 United Fire Group...

- - Launch of ORLYNVAH TM Expected August 2025— - -Cash Runway into 2026-- --Company to host conference call today at 8:30amET-- DUBLIN and CHICAGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on deli...

Iterum Therapeutics plc (ITRM) is expected to report $-0.13 for Q2 2025

2025-08-04 18:00:38 ET Major earnings expected before the bell on Tuesday include: Pfizer ( PFE ) Caterpillar ( CAT ) BP p.l.c. ( BP ) Organon & Co. ( OGN ) Duke Energy Corporation ( DUK ) Read the full article on Seeking Alpha For...

2025-08-04 11:31:46 ET More on Iterum Therapeutics Iterum targets ORLYNVAH US launch by Q4 2025 while extending cash runway into 2026 Iterum Therapeutics Non-GAAP EPS of -$0.10 Seeking Alpha’s Quant Rating on Iterum Therapeutics Historical earnings dat...

DUBLIN, Ireland and CHICAGO, July 29, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Company), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today anno...

DUBLIN and CHICAGO, July 02, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (“Iterum” or the “Company”), a company committed to delivering next generation oral and IV antibiotics to address infections caused by multi-drug resistant pathogens, today ann...